James P. ONeill - Mar 1, 2022 Form 4 Insider Report for Houghton Mifflin Harcourt Co (HMHC)

Role
EVP, GM, Core Curriculum
Signature
s/ William F. Bayers, Attorney-in-Fact
Stock symbol
HMHC
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/3/2022, 03:58 PM
Next filing
Mar 4, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This grant of restricted stock units has a vesting schedule of three equal installments (one on each of the first three anniversaries of the grant date), subject to continued employment with Houghton Mifflin Harcourt Company (the "Company"). Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting.

Remarks:

William F. Bayers is the Executive Vice President, Secretary and General Counsel of the Company.